<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>8(6)</volume><submitter>Mandai Y</submitter><pubmed_abstract>CD4(+) T cells play a central role in the development of inflammatory bowel disease (IBD) via high-level production of effector cytokines such as IFN-γ and TNF-α. To better characterize the colitogenic CD4(+) T cells, we examined their expression of CXCR6, a chemokine receptor that is expressed by T cells upon activation and is upregulated in several inflammatory diseases. We found that 80% of colonic lamina propria CD4(+) T cells expressed CXCR6 in the CD45RB(high) T cell-transferred colitis model. CXCR6 expression was similarly upregulated in inflamed mucosa of patients with Crohn's disease. Although surface marker analysis demonstrated that both CXCR6(+) and CXCR6(-) CD4(+) T-cell subsets consist of the cells with effector and effector-memory cells, the more cells in the CXCR6(+) subset</pubmed_abstract><journal>PloS one</journal><pagination>e65488</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC3686755</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>Distinct Roles for CXCR6(+) and CXCR6(-) CD4(+) T Cells in the Pathogenesis of Chronic Colitis.</pubmed_title><pmcid>PMC3686755</pmcid><pubmed_authors>Obata Y</pubmed_authors><pubmed_authors>Takahashi D</pubmed_authors><pubmed_authors>Shimaoka T</pubmed_authors><pubmed_authors>Furusawa Y</pubmed_authors><pubmed_authors>Katsuno T</pubmed_authors><pubmed_authors>Saito Y</pubmed_authors><pubmed_authors>Yokosuka O</pubmed_authors><pubmed_authors>Ebisawa M</pubmed_authors><pubmed_authors>Mandai Y</pubmed_authors><pubmed_authors>Sato T</pubmed_authors><pubmed_authors>Yokote K</pubmed_authors><pubmed_authors>Nakagawa T</pubmed_authors><pubmed_authors>Ohno H</pubmed_authors><pubmed_authors>Hase K</pubmed_authors></additional><is_claimable>false</is_claimable><name>Distinct Roles for CXCR6(+) and CXCR6(-) CD4(+) T Cells in the Pathogenesis of Chronic Colitis.</name><description>CD4(+) T cells play a central role in the development of inflammatory bowel disease (IBD) via high-level production of effector cytokines such as IFN-γ and TNF-α. To better characterize the colitogenic CD4(+) T cells, we examined their expression of CXCR6, a chemokine receptor that is expressed by T cells upon activation and is upregulated in several inflammatory diseases. We found that 80% of colonic lamina propria CD4(+) T cells expressed CXCR6 in the CD45RB(high) T cell-transferred colitis model. CXCR6 expression was similarly upregulated in inflamed mucosa of patients with Crohn's disease. Although surface marker analysis demonstrated that both CXCR6(+) and CXCR6(-) CD4(+) T-cell subsets consist of the cells with effector and effector-memory cells, the more cells in the CXCR6(+) subset</description><dates><release>2013-01-01T00:00:00Z</release><publication>2013</publication><modification>2026-04-08T16:31:53.089Z</modification><creation>2026-04-08T06:32:53.89Z</creation></dates><accession>S-EPMC3686755</accession><cross_references><pubmed>23840334</pubmed><doi>10.1371/journal.pone.0065488</doi></cross_references></HashMap>